iPS cells used to correct genetic mutations that cause muscular dystrophy

This image shows immunofluorescence staining of skeletal cells differentiated from DMD-iPS cells. Untreated DMD skeletal cells do not express dystrophin due to the deletion of exon 44. However, after... Researchers at the Center for iPS Cell Research and Application , Kyoto University, show that induced pluripotent stem cells can be used to correct genetic mutations that cause Duchenne muscular dystrophy .

http://ift.tt/1vjT549